Notation to File

AFIRMELLE

Aurobindo Pharma Ltd

Re: 88361892 - Office Action   Hi. Yes. Please make the proposed examiners amendment. Thank you to your help.  Adam Rodriguez, Esq. Bleakley Platt & Schmidt, LLP One North Lexington Avenue White Plains, NY 10601   Direct Dial: (914) 287-6145 Facsimile: (914) 683-6956 Email: arodriguez@bpslaw.com   Website: http://www.bpslaw.com  BIO | VCARD   ******************** This e-mail, and any attachments thereto, is intended only for use by the addressee(s) named herein and may contain legally privileged and/or confidential information. If you are not the intended recipient of this e-mail, you are hereby notified that any dissemination, distribution or copying of this e-mail, and any attachments thereto, is strictly prohibited. If you have received this e-mail in error, please notify me by replying to this message and permanently delete the original and any copy of this e-mail and any printout thereof. On Dec 9, 2

NOTE TO THE FILE


SERIAL NUMBER:            88361892

DATE:                                12/10/2019

NAME:                               cboozer

NOTE:         

Searched:                                                             
     Google                            
     Lexis/Nexis                       
     OneLook
     Wikipedia
     Acronym Finder                         Protest evidence reviewed
     Other:

Checked:                                                             
     Geographic significance          
     Surname                          
     Translation
     ID with ID/CLASS mailbox

     Checked list of approved Canadian attorneys and agents

Discussed file with
Attorney/Applicant via:
    X   phone                               Left message with
    X   email                               Attorney/Applicant

     Requested Law Library search           Issued Examiner’s Amendment
     for:                                   and entered changes in TRADEUPS

        PRINT        DO NOT PRINT           Added design code in TRADEUPS
     Description of the mark
     Translation statement                  Re-imaged standard character
                                            drawing
     Negative translation statement             
     Consent of living individual           Contacted TM MADRID ID/CLASS
                                            about misclassified definite ID
     Changed TRADEUPS to:

     OTHER:

From: Adam Rodriguez <ARodriguez@bpslaw.com>
Sent: Tuesday, December 10, 2019 8:30 AM
To: Boozer, Chandel <Chandel.Boozer@USPTO.GOV>
Subject: Re: 88361892 - Office Action

 

Hi. Yes. Please make the proposed examiners amendment. Thank you to your help. 

Adam Rodriguez, Esq.

Bleakley Platt & Schmidt, LLP
One North Lexington Avenue
White Plains, NY 10601

 

Direct Dial: (914) 287-6145
Facsimile: (914) 683-6956

Email: arodriguez@bpslaw.com

 

Website: http://www.bpslaw.com 

BIO | VCARD

 

********************

This e-mail, and any attachments thereto, is intended only for use by the addressee(s) named herein and may contain legally privileged and/or confidential information. If you are not the intended recipient of this e-mail, you are hereby notified that any dissemination, distribution or copying of this e-mail, and any attachments thereto, is strictly prohibited. If you have received this e-mail in error, please notify me by replying to this message and permanently delete the original and any copy of this e-mail and any printout thereof.


On Dec 9, 2019, at 5:52 PM, Boozer, Chandel <Chandel.Boozer@uspto.gov> wrote:

Hi Adam –

 

If you amend applicant’s identification to “prescription contraceptive preparations” in Class 5, the 2(d) refusal will be withdrawn. If you’d like, you can give me authorization to make the identification change via examiner’s amendment, and I can make those changes and approve for publication.

 

Best,

 

Chandel

 

From: Adam Rodriguez <ARodriguez@bpslaw.com>
Sent: Sunday, December 8, 2019 9:32 AM
To: Boozer, Chandel <Chandel.Boozer@USPTO.GOV>
Subject: 88361892 - Office Action

 

Hello,

Would you have a few minutes to chat tomorrow about the above-referenced office action, for AFIRMELLE?

 

Thank you.

 

Adam

 

Adam Rodriguez, Esq.

Bleakley Platt & Schmidt, LLP
One North Lexington Avenue
White Plains, NY 10601

 

<image006.jpg>  <image007.jpg> <image008.jpg> <image009.png>

Direct Dial: (914) 287-6145
Facsimile:
(914) 683-6956

Email: arodriguez@bpslaw.com

 

Website: http://link.zixcentral.com/u/1f0c180e/JAu7nNYa6hGTRKu-FhC8Ow?u=http%3A%2F%2Fwww.bpslaw.com 

BIO | VCARD

<image010.png>

********************

This e-mail, and any attachments thereto, is intended only for use by the addressee(s) named herein and may contain legally privileged and/or confidential information. If you are not the intended recipient of this e-mail, you are hereby notified that any dissemination, distribution or copying of this e-mail, and any attachments thereto, is strictly prohibited. If you have received this e-mail in error, please notify me by replying to this message and permanently delete the original and any copy of this e-mail and any printout thereof.

 

 


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed